Biologic medications can be used to treat hidradenitis suppurativa. If your case of HS is severe, you might be a good candidate for biologic therapy. Doctors can determine how severe your case is by tracking things like how many nodules you have or how many body parts are affected by HS.
In this video, learn what other factors doctors consider when prescribing biologic therapy for HS, according to Erum Ilyas, MD, Dermatologist with Montgomery Dermatology in Pennsylvania.
Erum Ilyas, MD, is a Dermatologist and founder of Montgomery Dermatology, which merged with Schweiger Dermatology, in Pennsylvania.
References
Ballard, K., et al. (2023). Hidradenitis suppurativa. StatPearls.
Bechara, F. G., et al. (2021). Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa. JAMA Surgery.
Ludmann, P. (2022). Hidradenitis suppurativa: Overview. American Academy of Dermatology Association.
Ludmann, P. (2022). Hidradenitis suppurativa: Self-care. American Academy of Dermatology Association.
MedlinePlus. (2023). Hidradenitis suppurativa.
National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2022). Hidradenitis suppurativa (HS).
National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2022). Hidradenitis suppurativa (HS): Diagnosis, treatment, and steps to take.
U.S. Food and Drug Administration. (2018). HUMIRA (adalimumab) injection, for subcutaneous use [package insert].
U.S. Food and Drug Administration. (2023). COSENTYX (secukinumab) injection, for subcutaneous or intravenous use [package insert].
Why trust our experts?
